The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AHCO | -13.79% | -66.92% | -19.85% | -2% |
| S&P | +14.5% | +93.32% | +14.09% | +117% |
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.
The company posted a triple whiff, coming in under pundit projections for revenue, profitability, and top-line guidance.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $800.37M | -0.7% |
| Gross Profit | $144.46M | 25.0% |
| Gross Margin | 18.05% | 3.7% |
| Market Cap | $1.27B | -4.5% |
| Market Cap / Employee | $0.12M | 0.0% |
| Employees | 10.5K | -1.9% |
| Net Income | $14.59M | -22.7% |
| EBITDA | $160.72M | 0.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $68.63M | -1.7% |
| Accounts Receivable | $393.59M | -9.9% |
| Inventory | 148.9 | 20.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $1.89B | -11.9% |
| Short Term Debt | $59.69M | -27.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 1.65% | 15.9% |
| Return On Invested Capital | -5.08% | 1.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $73.33M | -37.2% |
| Operating Free Cash Flow | $161.99M | -18.2% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change | |
|---|---|---|---|---|---|
| Price to Earnings | 15.74 | 19.10 | 17.63 | - | |
| Price to Book | 0.98 | 0.83 | 0.93 | 0.79 | -10.21% |
| Price to Sales | 0.47 | 0.40 | 0.45 | 0.40 | -4.39% |
| Price to Tangible Book Value | -1.08 | -0.96 | -1.21 | -1.07 | 13.89% |
| Price to Free Cash Flow TTM | 6.69 | 5.51 | 5.32 | 5.59 | -31.68% |
| Enterprise Value to EBITDA | 20.93 | 16.97 | 26.91 | 19.79 | -10.58% |
| Free Cash Flow Yield | 15.0% | 18.1% | 18.8% | 17.9% | 46.38% |
| Return on Equity | -13.4% | 5.5% | 5.1% | 4.8% | -112.60% |
| Total Debt | $2.18B | $2.13B | $2.10B | $1.95B | -12.51% |
AHCO earnings call for the period ending June 30, 2022.
AHCO earnings call for the period ending March 31, 2022.
AHCO earnings call for the period ending December 31, 2021.
AHCO earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
